This e-learning course discusses treatment sequencing in advanced digestive neuroendocrine tumours (NETs). The course provides an overview of available treatment options and the key trials that have influenced the ENETS consensus guidelines.
Two different treatment approaches are presented after the overview of the available treatments:
- Treatment choices for Metastatic low-grade SI-NET
- Treatment choices for Metastatic grade 2 pNET
Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms whose incidence has increased significantly in recent years, and whose optimal management remains controversial. This course reviews a number of recently reported trials looking at potential treatments options with: Multiple Kinase Inhibitors, Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy (PRRT).